2023
DOI: 10.5114/aoms/159180
|View full text |Cite
|
Sign up to set email alerts
|

Impact of platelet endothelial aggregation receptor 1 genotypes and DNA methylation on platelet reactivity in patients with recurrent ischemic stroke treated with clopidogrel

Abstract: IntroductionThe aim of this study is to investigate the role of genetic variation and DNA methylation of PEAR1 rs12041331 in high on-treatment platelet reactivity (HPR) and recurrent ischemic stroke (RIS).Material and methodsGenotype, methylation, and mRNA of PEAR1 rs12041331 were detected in patients with cerebral ischemia, for the analysis of the effect of PEAR1 rs12041331 on HPR and RIS.ResultsThe major G allele of PEAR1 rs12041331 was associated with hypermethylation, which was associated with HPR. This li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…[ 21 23 ] Although genetic variant PEAR1 rs12041331 was not associated with cardiovascular events in response to low-dose aspirin in a healthy elderly population, genotypes of PEAR1 had impact on platelet reactivity in patients with recurrent IS treated with clopidogrel. [ 24 , 25 ] In addition, PTGS1 gene variations associated with bleeding and platelet dysfunction and PTGS1 gene-smoking interaction might in part reflect the heterogeneity in the prognosis of stroke patients treated with aspirin. [ 26 ] Nevertheless, the association between genetic variations in PEAR1 and PTGS1 and the recurrence of IS treated with aspirin has not been adequately evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…[ 21 23 ] Although genetic variant PEAR1 rs12041331 was not associated with cardiovascular events in response to low-dose aspirin in a healthy elderly population, genotypes of PEAR1 had impact on platelet reactivity in patients with recurrent IS treated with clopidogrel. [ 24 , 25 ] In addition, PTGS1 gene variations associated with bleeding and platelet dysfunction and PTGS1 gene-smoking interaction might in part reflect the heterogeneity in the prognosis of stroke patients treated with aspirin. [ 26 ] Nevertheless, the association between genetic variations in PEAR1 and PTGS1 and the recurrence of IS treated with aspirin has not been adequately evaluated.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it is important to seek effective ways to improve the balance function of patients. Pharmacological treatment is usually used to improve the patient’s overall function, with little mention of single symptom improvement [ 8 ], while surgical treatment requires strict surgical indications [ 9 ] and is not the preferred option in the non-acute phase.…”
Section: Introductionmentioning
confidence: 99%